InterMune

The 3 Biggest Biotech Wins of the Week
Motley Fool
Wed, 05/28/14 - 10:52 am
GS-5806
Gilead Sciences
Factor XI inhibitor
Isis Pharmaceuticals
InterMune
pirfenidone
IPF
InterMune Gains After Lung Disease Drug Slows Damage
Bloomberg
Mon, 05/19/14 - 09:36 am
InterMune
pirfenidone
IPF
idiopathic pulmonary fibrosis
Biotech Stock Mailbag: Previewing InterMune's Big Week Ahead
TheStreet.com
Fri, 05/16/14 - 10:07 am
InterMune
IPF
idiopathic pulmonary fibrosis
Boehringer Ingelheim
pirfenidone
nintedanib
What's Hurting Biotechnology Stocks?
Seeking Alpha
Tue, 05/13/14 - 11:37 am
biotech
Gilead Sciences
InterMune
MannKind
Amgen
Celgene
Biogen Idec
Despite Esbriet Sales Nearly Tripling, InterMune's Loss Widens by 7%
Motley Fool
Fri, 05/2/14 - 08:37 am
earnings
InterMune
Better Buyout Candidate: Chelsea Therapeutics International Ltd. vs. InterMune Inc.
Motley Fool
Mon, 03/17/14 - 05:05 pm
Chelsea Therapeutics
Northera
Esbriet
idiopathic pulmonary fibrosis
InterMune
InterMune Rises on Takeover Rumour
Yahoo/Zacks.com
Mon, 03/10/14 - 05:05 pm
M&A
InterMune
Sanofi
Esbriet
Boehringer Ingelheim
Novartis
3 Biotech Stocks Spiking on Big Volume
TheStreet.com
Mon, 03/10/14 - 08:23 am
InterMune
Aegerion
Emergent BioSolutions
InterMune Wins Amid More Takeover Rumors
Motley Fool
Sat, 03/8/14 - 10:35 am
InterMune
Drugmaker InterMune attracts takeover interest -sources
Yahoo/Reuters
Fri, 03/7/14 - 12:09 pm
InterMune
M&A
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
InterMune
Esbriet
Alexion
Soliris
Vivus
Qsymia
Regeneron
Eylea
The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28
Forbes
Mon, 03/3/14 - 08:12 am
InterMune
Prana Biotechnology
Cara Therapeutics
Prothena
Endologix
Ampio Pharmaceuticals
Questcor Pharmaceuticals
Aegerion
InterMune Stuns Markets, but Is It Overvalued?
Motley Fool
Sat, 03/1/14 - 11:51 am
InterMune
InterMune Hits Home Run With Pivotal Lung Drug Study Results
TheStreet.com
Tue, 02/25/14 - 08:14 am
InterMune
pirfenidone
IPF
idiopathic pulmonary fibrosis
[video]Biotech Losers: InterMune, Enanta, and GW Pharmaceuticals
Motley Fool
Fri, 02/7/14 - 10:49 am
InterMune
GW Pharma
Enanta
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Wed, 01/22/14 - 08:41 am
Teva Pharmaceuticals
M&A
Idenix
Insmed
NuPathe
InterMune
Puma Biotechnology
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
biotech
M&A
Alexion
Biomarin
Incyte
Medivation
Idenix
Insmed
InterMune
Puma Biotechnology
Vertex Pharmaceuticals
InterMune: Esbriet And Ascend Will Drive Growth
Seeking Alpha
Sat, 12/21/13 - 11:32 am
InterMune
Esbriet
idiopathic pulmonary fibrosis
Supreme Court refuses to hear ex-InterMune CEO's appeal
Yahoo/Reuters
Mon, 12/16/13 - 02:14 pm
Supreme Court
InterMune
Actimmune
InterMune says it is selling 6.5M shares to fund marketing and studies of lung disease drug
Yahoo/AP
Wed, 11/6/13 - 11:21 am
InterMune
stock offering
Esbriet

Pages